Pacific Biosciences Of California | PACB - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agilent USD 2.27B 35M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Danaher USD 7.46B 653M 2026-03
General Electric Aerospace USD 40.03B 1.05B 2026-03
Illumina USD 1.57B 19M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
Pacific Biosciences Of California USD 65.36M 7.48M 2026-03
Quidel USD 962.4M 3.7M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Roche Holding CHF 28B 421M 2025-12
Standard Biotools USD 42.2M 66.1M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Waters USD 1.24B 11.8M 2025-12